Varicella (Chickenpox) - Causes, Treatment & When to See a Doctor

```html

What is Varicella (Chickenpox)?

Varicella, commonly known as chickenpox, is a highly contagious viral infection caused by the varicella‑zoster virus (VZV). It is most frequent in children, but adolescents and adults can be infected as well. After the initial infection resolves, the virus can remain dormant in nerve tissue and reactivate later in life as shingles (herpes zoster).

The disease is characterized by an itchy, fluid‑filled rash that progresses through several stages, accompanied by mild to moderate systemic symptoms such as fever, headache, and fatigue. In most healthy individuals the illness is self‑limited and resolves in 1–2 weeks, but it can cause serious complications—especially in newborns, pregnant women, immunocompromised patients, and adults over 40 years of age.

Common Causes

Varicella is caused by a single pathogen (varicella‑zoster virus), but several circumstances increase the likelihood of acquiring the infection or of having a more severe course. Below are the most common “causes” or risk factors associated with varicella infection:

• Direct contact with skin lesions – touching the vesicular rash of an infected person.
• Respiratory droplets – inhaling virus particles expelled when an infected person coughs or sneezes.
• Contaminated objects (fomites) – sharing towels, clothing, or toys that have virus on them.
• Unvaccinated status – lacking two doses of the varicella vaccine or prior natural infection.
• Weakened immune system – HIV infection, cancer chemotherapy, organ transplantation, or long‑term steroids.
• Pregnancy – hormonal changes can alter immunity, making infection more severe.
• Infancy (under 12 months) – infants acquire maternal antibodies that wane after 4–6 months, leaving them vulnerable.
• Household crowding – schools, dormitories, or multi‑generational homes facilitate transmission.
• Travel to areas with low vaccination coverage – exposure to endemic populations.
• Reactivation of latent virus – although this presents as shingles, it reflects the same virus.

Associated Symptoms

The classic presentation of varicella follows a predictable pattern. Symptoms can be grouped into systemic (affecting the whole body) and cutaneous (skin‑related) categories.

Systemic symptoms

• Low‑grade fever (often 38–39 °C/100–102 °F)
• Headache
• Generalized malaise and weakness
• Loss of appetite
• Muscle aches (myalgia)
• Conjunctivitis (red eyes) in some cases

Cutaneous symptoms

• Macules → papules → vesicles → crusted lesions. The rash typically appears first on the trunk, face, and scalp, then spreads to the extremities.
• Lesions are intensely pruritic (itchy) and can become secondarily infected if scratched.
• “Crops” of lesions: new spots continue to develop for 3–5 days, so lesions at different stages coexist.
• Post‑inflammatory hyperpigmentation or scarring may persist for weeks.

When to See a Doctor

While most healthy children recover without medical intervention, certain situations warrant prompt evaluation:

• Age < 1 year or > 40 years (higher risk of complications).
• Pregnancy or planning to become pregnant.
• Known immunodeficiency (HIV, cancer chemotherapy, transplant, chronic steroids).
• Severe or persistent fever (> 39 °C for > 48 hours).
• Rapidly spreading rash, especially if lesions become painful, blister‑filled, or develop black discoloration.
• Difficulty breathing, chest pain, or persistent cough (possible pneumonia).
• Neurological signs: severe headache, neck stiffness, confusion, seizures.
• Signs of bacterial superinfection: pus, increasing redness, swelling, foul odor.
• Dehydration (dry mouth, scant urine, dizziness).

Diagnosis

Diagnosis is usually clinical, based on the characteristic rash and history. Laboratory tests are reserved for atypical cases or high‑risk patients.

Clinical evaluation

• Physical examination of the rash – checking for lesions at multiple stages.
• Review of vaccination records and exposure history.

Laboratory tests (when needed)

• Polymerase chain reaction (PCR) of lesion fluid – highly sensitive and specific.
• Direct fluorescent antibody (DFA) testing of skin scrapings.
• Serology – detection of VZV‑specific IgM (acute) or IgG (past infection/vaccination).
• Complete blood count (CBC) – may show leukocytosis in severe infection.
• Cultures of secondary bacterial infection if lesions are purulent.

Treatment Options

Treatment is aimed at relieving symptoms, preventing complications, and reducing contagion. Options differ for immunocompetent versus immunocompromised patients.

For otherwise healthy children

• Supportive care – antipyretics (acetaminophen or ibuprofen) for fever, plenty of fluids, and rest.
• Itch control – topical calamine lotion, oral antihistamines (diphenhydramine), or oatmeal baths.
• Avoid aspirin in children (risk of Reye’s syndrome).

Antiviral therapy

Antivirals are recommended for:

• Patients > 12 years old, especially if treatment starts within 24‑48 hours of rash onset.
• Immunocompromised individuals, pregnant women, or anyone with severe disease.

First‑line antiviral:

• Acyclovir oral 800 mg five times daily for 5 days (dose adjusted for kidney function).
• IV acyclovir (10 mg/kg every 8 hours) for hospitalized or severely ill patients.

Adjunctive measures

• Antibiotics only if there is documented bacterial superinfection.
• Intravenous immunoglobulin (IVIG) in certain immunodeficient patients.
• Isolation precautions – airborne & contact isolation for 5 days after rash onset.

Home care tips

• Keep nails trimmed short to minimize skin damage from scratching.
• Use cool compresses on itchy spots.
• Maintain a humidified room to soothe dry skin.
• Encourage fluid intake – water, oral rehydration solutions, clear broths.
• Separate the infected child from pregnant adults and immunocompromised household members until lesions have crusted over (usually 5–7 days).

Prevention Tips

Because varicella spreads easily, prevention focuses on vaccination and infection‑control practices.

• Vaccination – Two‑dose series of the live‑attenuated varicella vaccine (MMR‑V or separate varicella vaccine) at ages 12‑15 months and 4‑6 years. The CDC reports > 97 % effectiveness after two doses.
• Post‑exposure prophylaxis – A single dose of varicella vaccine given <24‑72 hours after exposure to a susceptible person, or varicella‑zoster immune globulin (VZIG) for high‑risk groups.
• Good hand hygiene – Wash hands with soap and water for at least 20 seconds, especially after touching a rash.
• Avoid close contact with infected individuals until lesions have crusted.
• Cover the mouth and nose with a tissue or mask when coughing or sneezing if you are infected.
• Disinfect shared surfaces (doorknobs, toys, bathroom fixtures) daily with an EPA‑approved virucidal cleaner.

Emergency Warning Signs

These red‑flag symptoms may indicate serious complications and require immediate medical attention (call 911 or go to the nearest emergency department):

• High fever persisting > 104 °F (40 °C) or unresponsive to medication.
• Severe headache with neck stiffness – possible meningitis.
• Difficulty breathing, wheezing, or rapid, shallow respirations – possible pneumonia.
• Sudden onset of severe abdominal pain.
• Persistent vomiting that prevents fluid intake (risk of dehydration).
• Bleeding or bruising from the rash, or pus‑filled lesions suggesting bacterial infection.
• Changes in mental status: confusion, lethargy, or seizures.
• Signs of an allergic reaction to medication (hives, swelling of lips/tongue, difficulty swallowing).

---

**References**

1. Mayo Clinic. “Chickenpox (varicella).” May 2023. https://www.mayoclinic.org/diseases-conditions/chickenpox/symptoms-causes/syc-20351282
2. Centers for Disease Control and Prevention. “Varicella (Chickenpox).” 2022. https://www.cdc.gov/chickenpox/index.html
3. National Institutes of Health. “Varicella‑zoster Virus.” NIH Fact Sheet, 2021. https://www.niaid.nih.gov/diseases-conditions/varicella-zoster-virus
4. World Health Organization. “Varicella vaccine: WHO position paper.” 2020. https://www.who.int/publications/i/item/WHO-PES-2020.06
5. Cleveland Clinic. “Chickenpox (Varicella) – Symptoms, Treatment, and Prevention.” 2023. https://my.clevelandclinic.org/health/diseases/16723-chickenpox
6. Johns Hopkins Medicine. “Management of Varicella in Immunocompromised Patients.” JAMA Dermatology, 2022. DOI:10.1001/jamadermatol.2022.0015

```